Evidence map›Paper›PMID 37765320›Full record

ArticlePharmaceutics2023

l-Asparaginase Type II from

Samuel Leite Cardoso, Paula Monteiro Souza, Kelly Rodrigues, Isabella de Souza Mota, Edivaldo Ferreira Filho, Léia Cecilia de Lima Fávaro, Felipe Saldanha-Araujo, Mauricio Homem-de-Mello, Adalberto Pessoa, Dâmaris Silveira and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Samuel Leite CardosoHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.
Paula Monteiro SouzaHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0003-1824-2211
Kelly RodriguesBrazilian Agricultural Research Corporation-EMBRAPA Agroenergia, Brasilia 70770-901, Brazil.ORCID 0009-0002-9014-3488
Isabella de Souza MotaHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.
Edivaldo Ferreira FilhoInstitute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0003-4947-8753
Léia Cecilia de Lima FávaroBrazilian Agricultural Research Corporation-EMBRAPA Agroenergia, Brasilia 70770-901, Brazil.ORCID 0000-0003-3260-0310
Felipe Saldanha-AraujoHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.
Mauricio Homem-de-MelloHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0002-4541-9177
Adalberto PessoaDepartment of Biochemical and Pharmaceutical Technology, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0002-5268-8690
Dâmaris SilveiraHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0003-1851-5224
Yris Maria Fonseca-BazzoHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0002-1230-3207
Pérola Oliveira MagalhãesHealth Science School, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0001-8011-6940
Universidade de Brasília · BRBrazilian Agricultural Research Corporation · BRUniversidade de São Paulo · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001National Council for Scientific and Technological Development 310373/2020-4São Paulo Research Foundation 193.0000919-2020/07
6 · The paper itself

Abstract

The search for new drug-producing microorganisms is one of the most promising situations in current world scientific scenarios. The use of molecular biology as well as the cloning of protein and compound genes is already well established as the gold standard method of increasing productivity. Aiming at this increase in productivity, this work aims at the cloning, purification and in silico analysis of l-asparaginase from

Indexed as

Fusarium proliferatumheterologous expressionin silico analysisl-asparaginase

Identifiers

PMID37765320
PMCPMC10534586
OpenAlexW4386879406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.